# Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve

> **NCT05397106** · — · ACTIVE_NOT_RECRUITING · sponsor: **Integra LifeSciences Corporation** · enrollment: 160 (actual)

## Conditions studied

- Hydrocephalus
- Hydrocephalus in Children
- NPH (Normal Pressure Hydrocephalus)
- IIH - Idiopathic Intracranial Hypertension
- Brain Tumor
- Post-Traumatic Hydrocephalus
- Hemorrhagic Stroke

## Interventions

- **DEVICE:** CODMAN CERTAS Plus Programmable Valve

## Key facts

- **NCT ID:** NCT05397106
- **Lead sponsor:** Integra LifeSciences Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-01-24
- **Primary completion:** 2029-01-24
- **Final completion:** 2029-01-24
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05397106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05397106, "Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05397106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*